CIRCADIAN NEUROENDOCRINE RESETTING THERAPY
Live / Registered — Registered and renewed (as of 31 Aug 2021)
What this means for you
Registered since 26 Apr 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Apr 2021).
Record
- Serial number
- 85037493
- Registration number
- 3952824
- Mark type
- Stylized text
- Filed
- 13 May 2010
- Registered
- 26 Apr 2011
- Next maintenance due
- 26 Apr 2021
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 044 — Medical, beauty and agricultural services: Treatment of obesity, lipid disorders, metabolic disorders, cardiovascular diseases, diseases of the immune system, age-related diseases, cancer, and diseases caused by diabetes such as diabetic neuropathy, obesity, dyslipidemia, hypercholestermia, and hypertension through the therapy of changing the aberrant phase relationships of specific pacemaker biological clock circadian peak neuronal outputs, e.g., messaging or transmission, within the central nervous system
Owner
- VeroScience LLC, Tiverton, RI, US
- VeroScience LLC, Tiverton, RI, US
Prosecution history
- 31 Aug 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 31 Aug 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 31 Aug 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Aug 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 24 Aug 2021 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 11 Aug 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Apr 2021 — TEAS SECTION 8 & 9 RECEIVED
- 26 Apr 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 May 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 17 May 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 17 May 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Apr 2016 — TEAS SECTION 8 RECEIVED
- 26 Apr 2011 — REGISTERED-SUPPLEMENTAL REGISTER
- 21 Mar 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 18 Mar 2011 — ASSIGNED TO LIE